Coordinated prophylactic surgical management for women with hereditary breast-ovarian cancer syndrome

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Batista, Larissa I ^a   Lu, Karen H ^a   Beahm, Elisabeth K ^a   Arun, Banu K ^a   Bodurka, Diane C ^a   Meric Bernstam, Funda ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; TAMOXIFEN; BRAP PROTEIN, HUMAN; BRCA2 PROTEIN; BRCA2 PROTEIN, HUMAN; UBIQUITIN PROTEIN LIGASE;

ADULT; AGED; ARTICLE; ASPIRATION PNEUMONIA; BREAST CANCER; BREAST RECONSTRUCTION; CANCER RECURRENCE; CANCER RISK; CLINICAL ARTICLE; EPIDERMOLYSIS; FAMILIAL CANCER; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MASTECTOMY; MORBIDITY; OPERATION DURATION; OUTCOME ASSESSMENT; OVARY CANCER; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; REOPERATION; RETROSPECTIVE STUDY; SALPINGOOOPHORECTOMY; TISSUE FLAP; WOUND DEHISCENCE; BREAST TUMOR; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE; MIDDLE AGED; OVARIECTOMY; OVARY TUMOR;

ADULT; AGED; BRCA2 PROTEIN; BREAST NEOPLASMS; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MASTECTOMY; MIDDLE AGED; NEOPLASTIC SYNDROMES, HEREDITARY; OVARIAN NEOPLASMS; OVARIECTOMY; RETROSPECTIVE STUDIES; UBIQUITIN-PROTEIN LIGASES;

EID: 42949146464     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-101     Document Type: Article

References (20)

1. Ford D Easton DF Stratton M Narod S Goldgar D Devilee P Bishop DT Weber B Lenoir G Chang-Claude J Sobol H Teare MD Struewing J Arason A Scherneck S Peto J Rebbeck TR Tonin P Neuhausen S Barkardottir R Eyfjord J Lynch H Ponder BA Gayther SA Zelada-Hedman M: Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998, 62(3):676-689. 1376944 9497246 10.1086/301749
2. Antoniou A Pharoah PD Narod S Risch HA Eyfjord JE Hopper JL Loman N Olsson H Johannsson O Borg A Pasini B Radice P Manoukian S Eccles DM Tang N Olah E Anton-Culver H Warner E Lubinski J Gronwald J Gorski B Tulinius H Thorlacius S Eerola H Nevanlinna H Syrjakoski K Kallioniemi OP Thompson D Evans C Peto J Lalloo F Evans DG Easton DF: Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: A combined analysis of 22 studies. Am J Hum Genet 2003, 72(5):1117-1130. 1180265 12677558 10.1086/375033
3. Oros KK Ghadirian P Maugard CM Perret C Paredes Y Mes-Masson AM Foulkes WD Provencher D Tonin PN: Application of BRCA1 and BRCA2 mutation carrier prediction models in breast and/or ovarian cancer families of French Canadian descent. Clin Genet 2006, 70(4):320-329. 10.1111/ j.1399-0004.2006.00673.x 16965326
4. Risch HA McLaughlin JR Cole DE Rosen B Bradley L Fan I Tang J Li S Zhang S Shaw PA Narod SA: Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: A kin-cohort study in Ontario, Canada. J Natl Cancer Inst 2006, 98(23):1694-1706. 17148771
5. Metcalfe K Lynch HT Ghadirian P Tung N Olivotto I Warner E Olopade OI Eisen A Weber B McLennan J Sun P Foulkes WD Narod SA: Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 2004, 22(12):2328-2335. 10.1200/JCO.2004.04.033 15197194
6. Pierce LJ Levin AM Rebbeck TR Ben-David MA Friedman E Solin LJ Harris EE Gaffney DK Haffty BG Dawson LA Narod SA Olivotto IA Eisen A Whelan TJ Olopade OI Isaacs C Merajver SD Wong JS Garber JE Weber BL: Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer. J Clin Oncol 2006, 24(16):2437-2443. 10.1200/JCO.2005.02.7888 16636335
7. National Comprehensive Cancer Network: Clinical Practice Guidelines in Oncology. Genetic/familial high risk assessment: Breast and ovarian http://www.nccn.org/professionals/physician_gls/pdf/ genetics_screening.pdf
8. Cuzick J Powles T Veronesi U Forbes J Edwards R Ashley S Boyle P: Overview of the main outcomes in breast-cancer prevention trials. Lancet 2003, 361(9354):296-300. 10.1016/S0140-6736(03)12342-2 12559863
9. Gronwald J Tung N Foulkes WD Offit K Gershoni R Daly M Kim-Sing C Olsson H Ainsworth P Eisen A Saal H Friedman E Olopade O Osborne M Weitzel J Lynch H Ghadirian P Lubinski J Sun P Narod SA: Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: An update. Int J Cancer 2006, 118(9):2281-2284. 10.1002/ijc.21536 16331614
10. Rebbeck TR Lynch HT Neuhausen SL Narod SA Van't Veer L Garber JE Evans G Isaacs C Daly MB Matloff E Olopade OI Weber BL: Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 2002, 346(21):1616-1622. 10.1056/NEJMoa012158 12023993
11. Kauff ND Satagopan JM Robson ME Scheuer L Hensley M Hudis CA Ellis NA Boyd J Borgen PI Barakat RR Norton L Castiel M Nafa K Offit K: Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 2002, 346(21):1609-1615. 10.1056/NEJMoa020119 12023992
12. Rebbeck TR Friebel T Lynch HT Neuhausen SL van't Veer L Garber JE Evans GR Narod SA Isaacs C Matloff E Daly MB Olopade OI Weber BL: Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: The PROSE Study Group. J Clin Oncol 2004, 22(6):1055-1062. 10.1200/JCO.2004.04.188 14981104
13. Domchek SM Rebbeck TR: Prophylactic oophorectomy in women at increased cancer risk. Curr Opin Obstet Gynecol 2007, 19(1):27-30. 17218848
14. Easton DF Ford D Bishop DT: Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 1995, 56(1):265-271. 1801337 7825587
15. Schrag D Kuntz KM Garber JE Weeks JC: Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations. Jama 2000, 283(5):617-624. 10.1001/jama.283.5.617 10665701
16. Chang EI Ly DP Wey PD: Comparison of aesthetic breast reconstruction after skin-sparing or conventional mastectomy in patients receiving preoperative radiation therapy. Ann Plast Surg 2007, 59(1):78-81. 10.1097/01.sap.0000252487.27077.d6 17589266
17. Jugenburg M Disa JJ Pusic AL Cordeiro PG: Impact of radiotherapy on breast reconstruction. Clin Plast Surg 2007, 34(1):29 37; abstract v-vi 10.1016/j.cps.2006.11.013 17307069
18. Goldflam K Hunt KK Gershenwald JE Singletary SE Mirza N Kuerer HM Babiera GV Ames FC Ross MI Feig BW Sahin AA Arun B Meric-Bernstam F: Contralateral prophylactic mastectomy. Predictors of significant histologic findings. Cancer 2004, 101(9):1977-1986. 10.1002/cncr.20617 15389473
19. Chang DW Reece GP Wang B Robb GL Miller MJ Evans GR Langstein HN Kroll SS: Effect of smoking on complications in patients undergoing free TRAM flap breast reconstruction. Plast Reconstr Surg 2000, 105(7):2374-2380. 10.1097/00006534-200006000-00010 10845289
20. Schmeler KM Sun CC Bodurka DC White KG Soliman PT Uyei AR Erlichman JL Arun BK Daniels MS Rimes SA Peterson SK Slomovitz BM Milam MR Gershenson DM Lu KH: Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations. Obstet Gynecol 2006, 108(3 Pt 1):515-520. 16946209